Maturing Chinese market gives WellPoint new prospects
Premiums for private health insurers in China are expected to rise to $90 billion by 2020 from $9 billion now, and WellPoint Inc. is angling for a big piece of that pie.
Premiums for private health insurers in China are expected to rise to $90 billion by 2020 from $9 billion now, and WellPoint Inc. is angling for a big piece of that pie.
VMS, an Indianapolis-based marketing firm specializing in pharmaceutical and biotechnology firms, has hired Phil Belt as its chief operating officer. Belt previously was a vice president at Credit Suisse, focused on private-equity investments in life sciences. Before that, he oversaw the product and corporate communications teams at Eli Lilly and Co.
Dr. Techsin T. Ty has been appointed medical director of Mississippi-based Great Lakes Home Health’s central Indiana service area. Ty practices internal medicine in Kokomo.
Dr. Steven G. Becker has been named interim assistant dean and interim director of the Indiana University School of Medicine’s Evansville branch. He succeeds Rex D. Stith, who had directed the Evansville campus for 18 years. Becker also will continue to serve as a professor of physiology.
Carmel-based CNO Financial Group Inc. hired John M. Bradley as vice president of product management for Medicare markets. Bradley, an actuary, comes from Illinois-based Combined Insurance Co.
Eli Lilly and Co. is starting a service program that sends employees around the world to help developing communities and learn about other cultures, as the drugmaker looks to international markets.
In this installment of IBJ's Who's Who series, meet key members of the city’s banking and finance sector. They include bankers, fund managers, venture capitalists, lawyers, financial planners and others who influence the movement and availability of money in the local economy.
The Children’s Museum of Indianapolis received a $1 million grant from the Eli Lilly and Co. Foundation to support expeditions by an Indiana University team to Captain Kidd’s ship in the Dominican Republic.
The city of Indianapolis went to the bond market last month to sell $97 million in debt for the $155 million North of South hotel and retail project near the Eli Lilly and Co. campus.
The Indianapolis law firm of Baker & Daniels LLP has promoted Brita A. Horvath to manager of diversity and pro bono.
City officials’ fear that Rolls-Royce Corp. might pull thousands of jobs out of Indianapolis drove the negotiations that culminated last month with the company’s committing to move 2,500 of its local office employees to the south side of downtown.
The study included Eli Lilly and Co. drug Cymbalta, which racked up sales of $3.5 billion last year for the Indianapolis-based drugmaker.
Advion, a provider of bioanalytical research and a subsidiary of Ithaca, N.Y.-based Advion BioSciences Inc., is expected to open the 22,000-square-foot lab in mid-May with 49 employees, according to the company’s application.
Physicians are regarded as smart, successful and helpful when you’re sick—but not usually as a big driver of the economy. Now, however, physician trade groups are arguing that docs are good for business too.
Indiana University will receive donations totaling $10.7 million from the estate of late philanthropist Ruth Lilly, the university announced Wednesday morning.
Meet the people who tweet for Indianapolis Symphony Orchestra, AAA, Butler University and other local businesses.
The Metropolitan Development Commission on Wednesday preliminarily approved Advion BioServices Inc.’s request for a tax abatement to build a laboratory at Purdue Research Park in Indianapolis.
We think city officials have made a compelling case for stepping up big to secure the future of one of Indianapolis’ largest employers.
TechPoint-led initiative is meant to help bring inventions to market by giving them a trial in real-world setting.
The total annual cost for one researcher at Lilly might run $300,000 to $350,000 a year. The figure at Crown Bioscience is one-third of that, said a company executive.
The Indiana University School of Medicine has licensed a pediatric psychiatrist’s patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed the patent to Indianapolis-based Confluence Pharmaceuticals Inc.